微创穿刺联合口服阿托伐他汀治疗慢性硬膜下血肿的疗效分析

doi:10.3877/cma.j.issn.2095-9141.2016.02.005

中华神经创伤外科电子杂志 ›› 2016, Vol. 02 ›› Issue (02) : 83 -85. doi: 10.3877/cma.j.issn.2095-9141.2016.02.005

所属专题：文献；

临床研究

微创穿刺联合口服阿托伐他汀治疗慢性硬膜下血肿的疗效分析

曹德茂¹, 武永康¹^,^†(

), 王友伟¹, 申宝玺¹, 王鸿生¹, 齐文涛¹

^1. 225000　扬州，扬州市第一人民医院神经外科

收稿日期:2015-05-25 出版日期:2016-04-15
通信作者: 武永康

The effect of minimally invasive puncture combined with oral atorvastatin on chronic subdural hematoma

Demao Cao¹, Yongkang Wu¹^,^†(), Youwei Wang¹, Baoxi Shen¹, Hongsheng Wang¹, Wentao Qi¹

^1. Department of Neurosurgery, the First People’s Hospital of Yangzhou, Yanzhou 225001, China

Received:2015-05-25 Published:2016-04-15
Corresponding author: Yongkang Wu
About author:
Corresponding author: Yongkang, Email: wuyongkang@163.com

全文 ( ) 下载PDF ( ) 导出引用

目的

探讨微创穿刺联合口服阿托伐他汀治疗慢性硬膜下血肿的效果、预后及复发。

方法

回顾性分析65例慢性硬膜下血肿患者，均进行微创穿刺，联合口服阿托伐他汀。

结果

65例患者均一次性治愈，并发不同程度气颅12例。术后癫痫l例。

结论

微创穿刺治疗慢性硬膜下血肿，具有手术时间短、操作简单、创伤小、恢复快等优点；联合口服阿托伐他汀，可有效降低复发率，改善预后，是适合临床推广的有效方法。

关键词: 微创穿刺术, 阿托伐他汀, 慢性硬膜下血肿, 治疗

Objective

To explore the effect of minimally invasive puncture combined with oral atorvastatin in the treatment of chronic subdural hematoma.

Methods

To review and analyze 65 cases of chronic subdural hematoma which were treated with minimally invasive puncture combined with atorvastatin.

Results

All the patients were cured. 12 patients had different degrees of pneumocephalus and one patients had epilepsy.

Conclusion

The minimally invasive treatment of chronic subdural hematoma has the advantages of short operation time, quick recovery and if combined with oral atorvastatin, it can effectively reduce the recurrence rate, which is suitable for clinical promotion.

Key words: Minimally invasive procedure, Atorvastatin, Chronic subdural hematoma, Treatment

图1 患者口服阿伐他丁的前后CT对比

图2 患者术前术后口服阿伐他丁的前后CT对比

[1]	Almenawer SA,Farrokhyar F,Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34829 patients[J]. Ann Surg, 2014, 259(3): 449-457.
[2]	Lee L,Ker J,Ng HY, et al. Outcomes of chronic subdural hematoma drainage in nonagenarians and centenarians: a multicenter study[J]. J Neurosurg, 2015, 10(7): 1-6.
[3]	Tanaka Y,Ohno K. Chronic subdural hematoma-an up-to-date concept[J]. J Med Dent Sci, 2013, 60(2): 55-61.
[4]	D′Abbondanza JA,Loch Macdonald R. Experimental models of chronic subdural hematoma[J]. Neurol Res, 2014, 36(2): 176-188.
[5]	Lega BC,Danish SF,Malhotra NR, et al. Choosing the best operation for chronic subdural hematoma: a decision analysis[J]. J Neurosurg, 2010, 113(3):615-621.
[6]	肖智勇,胡志强,朱广通,等.软性神经内镜在慢性硬膜下血肿术中的应用[J].中华神经外科杂志, 2015, 31(9): 888-890.
[7]	Lu J,Shen D,Hu F, et al. An improved electronic twist-drill craniostomy procedure with post-operative urokinase instillation in treating chronic subdural hematoma[J]. Clinl Neurol Neurosurg, 2015, 136(9): 61-65.
[8]	Li T,Wang D,Tian Y, et al. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats[J]. J Neurol Sci, 2014, 341(1-2): 88-96.
[9]	Wang D,Li T,Tian Y, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers[J]. J Neurol Sci, 2014, 336(1-2): 237-242.
[10]	Wood WG,Mller WE,Eckert GP. Statins and neuroprotection: basic pharmacology needed[J]. Mol neurobiol, 2014, 50(1): 214-220.
[11]	Tu Q,Cao H,Zhong W, et al. Atorvastatin protects against cerebral ischemia reperfusion injury through anti-inflammatory and antioxidant effects[J]. Neural Rege Res, 2014, 9(3): 268-275.
[12]	Martins WC,dos Santos VV,dos Santos AA, et al. Atorvastatin prevents cognitive deficits induced by intracerebroventricular amyloid-β1-40 administration in mice: involvement of glutamatergic and antioxidant systems[J]. Neurotox Res, 2015, 28(1): 32-42.
[13]	Drapkin AJ. Chronic subdural hematoma: pathophysiological basis for treatment[J]. Br Neurosurg, 1991, 5(5): 467-473.

[1]	史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(08): 778-784.
[2]	曹琮沅, 黄烁金, 何倩婷, 王安训. 平阳霉素复合剂治疗口腔颌面部脉管畸形的有效性和安全性[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 368-374.
[3]	李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4]	陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5]	梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6]	许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[7]	刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[8]	刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[9]	石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[10]	林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊（第15期）——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[11]	中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[12]	陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[13]	吴天宇, 刘子璇, 杨浦鑫, 贾思明, 丁凯, 程晓东, 李泳龙, 陈伟, 吕红芝, 张奇. 腰椎间盘突出症保守治疗进展[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 379-384.
[14]	崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15]	王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

The effect of minimally invasive puncture combined with oral atorvastatin on chronic subdural hematoma

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

The effect of minimally invasive puncture combined with oral atorvastatin on chronic subdural hematoma